The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation
of a stent, often a drug-eluting stent, though most published data originated in the era of bare …

Background Coronary artery bypass grafting (CABG) is the standard treatment for
revascularisation in patients with left main coronary artery disease, but use of percutaneous …

Background Percutaneous coronary intervention (PCI) is increasingly used to treat
unprotected left main coronary artery stenosis, although coronary-artery bypass grafting …

Background—Although intravascular ultrasound (IVUS) guidance has been useful in
stenting for unprotected left main coronary artery stenosis, its impact on long-term mortality is …

Background—Although drug-eluting stents (DES) significantly reduce restenosis, they
require 3 to 6 months of thienopyridine therapy to prevent stent thrombosis. The rate and …

Left main coronary artery (LMCA) disease is the highest-risk lesion subset of ischemic heart
disease, and has traditionally been an indication for coronary artery bypass grafting (CABG) …

Background Several studies have compared the treatment effects of coronary stenting and
coronary-artery bypass grafting (CABG). However, there are limited data regarding the long …

Objectives: The purpose of this study was to compare the early and late results of
percutaneous and surgical revascularization of left main coronary artery stenosis …

BACKGROUND: Changes in the treatment of coronary artery disease both surgically and
percutaneously have rendered the major randomized trials historical. Furthermore, the …